CCR5 blockage by maraviroc exposure also induced a steep decline in the percentage of viable cells in human and rat CRC cells in a dose-dependent format beyond 50 μM concentrations of the test compound (Fig. 1d). Here, CCR5 is linked to colorectal carcinoma.